Seaside Ventures

About The Fund

Seaside Ventures is an investment fund focused on fueling the future of health and wellness, with a passion for backing innovations that enhance health, boost happiness, and elevate quality of life. They prioritize investment in science-driven consumer health technologies and are positioned within the vast $4.5 trillion healthcare market. Their aim is to tackle the root causes of health challenges, paving the way for proactive and preventative care with a clear mission: to elevate the mental and physical well-being of over a billion people globally by making transformative innovation into accessible solutions that have a significant impact on lives at scale. Seaside Ventures is an active partner in the companies they invest in, serving as strategic allies in scaling their impact with a keen interest in products and services that maximize mental and physical health. With over 18 companies in their portfolio, Seaside Ventures engages in more than 50 strategic partnerships leveraging 25+ years of experience to bring groundbreaking solutions to market. Their investments range from in vitro spermatogenesis (IVS) technology for male infertility to advanced neurotechnology enhancing sleep quality, and from the world’s first genetically engineered probiotic to the most advanced digital clinics focused on prevention, performance, and longevity. Seaside Ventures commits to investments ranging from $50,000 to $500,000 with a sweet spot at $150,000, through stages from Pre-Seed to Series A. Their emphasis is on building companies that bridge the gap between scientific breakthroughs and commercial success to create market-leading solutions. They also provide comprehensive support in refining business models, optimizing operations, go-to-market strategies, and scaling customer acquisition. The fund takes pride in assisting startups in gaining visibility and operating within the ecosystem of industry expertise to transform validated innovations into commercial triumphs.